Outcomes of Bone Metastases treated with Radiotherapy in Lung Cancer
Not Applicable
- Conditions
- Health Condition 1: C348- Malignant neoplasm of overlappingsites of bronchus and lung
- Registration Number
- CTRI/2020/04/024780
- Lead Sponsor
- Dr Anil Tibdewal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All consecutive patients with histologically proven lung cancer with radiologically confirmed bone metastases and planned for radiotherapy at TMH.
2.All patients planned for radiotherapy at Tata Memorial Hospital.
Exclusion Criteria
1.Age <18 years
2.Patients who are not willing to come for follow up after EBRT completion.
3.Patients with spinal cord compression at presentation.
4.Patients requiring reirradiation at the previously treated site.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate objective pain response at 2 and 4 weeks (+/-3 days) in lung cancer patients treated with radiotherapy for bone metastasesTimepoint: 2 and 4 weeks
- Secondary Outcome Measures
Name Time Method To evaluate objective pain response of assessable patients at 3 and 6 months <br/ ><br>Time to reirradiation for the same site <br/ ><br>To evaluate the prognostic factors affecting the treatment response <br/ ><br>To subjectively assess the quality of life using EORTC QOL and BM 22 <br/ ><br>Timepoint: 3 months